Behavioural economic interventions to embed palliative care in community oncology (BE-EPIC) : study protocol for the BE-EPIC randomised controlled trial
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
INTRODUCTION: Palliative care (PC) is a medical specialty focusing on providing relief from the symptoms and stress of serious illnesses such as cancer. Early outpatient specialty PC concurrent with cancer-directed treatment improves quality of life and symptom burden, decreases aggressive end-of-life care and is an evidence-based practice endorsed by national guidelines. However, nearly half of patients with advanced cancer do not receive specialty PC prior to dying. The objective of this study is to test the impact of an oncologist-directed default PC referral orders on rates of PC utilisation and patient quality of life.
METHODS AND ANALYSIS: This single-centre two-arm pragmatic randomised trial randomises four clinician-led pods, caring for approximately 250 patients who meet guideline-based criteria for PC referral, in a 1:1 fashion into a control or intervention arm. Intervention oncologists receive a nudge consisting of an electronic health record message indicating a patient has a default pended order for PC. Intervention oncologists are given an opportunity to opt out of referral to PC. Oncologists in pods randomised to the control arm will receive no intervention beyond usual practice. The primary outcome is completed PC visits within 12 weeks. Secondary outcomes are change in quality of life and absolute quality of life scores between the two arms.
ETHICS AND DISSEMINATION: This study has been approved by the Institutional Review Board at the University of Pennsylvania. Study results will be disseminated in peer-reviewed journals and scientific conferences using methods that describe the results in ways that key stakeholders can best understand and implement.
TRIAL REGISTRATION NUMBER: NCT05365997.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
BMJ open - 13(2023), 3 vom: 24. März, Seite e069468 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parikh, Ravi B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical Trial Protocol |
|---|
| Anmerkungen: |
Date Completed 28.03.2023 Date Revised 08.04.2023 published: Electronic ClinicalTrials.gov: NCT05365997 Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjopen-2022-069468 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM354689193 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM354689193 | ||
| 003 | DE-627 | ||
| 005 | 20231226210135.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjopen-2022-069468 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1182.xml |
| 035 | |a (DE-627)NLM354689193 | ||
| 035 | |a (NLM)36963789 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parikh, Ravi B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Behavioural economic interventions to embed palliative care in community oncology (BE-EPIC) |b study protocol for the BE-EPIC randomised controlled trial |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.03.2023 | ||
| 500 | |a Date Revised 08.04.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT05365997 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a INTRODUCTION: Palliative care (PC) is a medical specialty focusing on providing relief from the symptoms and stress of serious illnesses such as cancer. Early outpatient specialty PC concurrent with cancer-directed treatment improves quality of life and symptom burden, decreases aggressive end-of-life care and is an evidence-based practice endorsed by national guidelines. However, nearly half of patients with advanced cancer do not receive specialty PC prior to dying. The objective of this study is to test the impact of an oncologist-directed default PC referral orders on rates of PC utilisation and patient quality of life | ||
| 520 | |a METHODS AND ANALYSIS: This single-centre two-arm pragmatic randomised trial randomises four clinician-led pods, caring for approximately 250 patients who meet guideline-based criteria for PC referral, in a 1:1 fashion into a control or intervention arm. Intervention oncologists receive a nudge consisting of an electronic health record message indicating a patient has a default pended order for PC. Intervention oncologists are given an opportunity to opt out of referral to PC. Oncologists in pods randomised to the control arm will receive no intervention beyond usual practice. The primary outcome is completed PC visits within 12 weeks. Secondary outcomes are change in quality of life and absolute quality of life scores between the two arms | ||
| 520 | |a ETHICS AND DISSEMINATION: This study has been approved by the Institutional Review Board at the University of Pennsylvania. Study results will be disseminated in peer-reviewed journals and scientific conferences using methods that describe the results in ways that key stakeholders can best understand and implement | ||
| 520 | |a TRIAL REGISTRATION NUMBER: NCT05365997 | ||
| 650 | 4 | |a Clinical Trial Protocol | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a health services administration & management | |
| 650 | 4 | |a oncology | |
| 650 | 4 | |a palliative care | |
| 700 | 1 | |a Sedhom, Ramy |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrell, William J |e verfasserin |4 aut | |
| 700 | 1 | |a Villarin, Katherine |e verfasserin |4 aut | |
| 700 | 1 | |a Berwanger, Kara |e verfasserin |4 aut | |
| 700 | 1 | |a Scarborough, Bethann |e verfasserin |4 aut | |
| 700 | 1 | |a Oyer, Randall |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Pallavi |e verfasserin |4 aut | |
| 700 | 1 | |a Ganta, Niharika |e verfasserin |4 aut | |
| 700 | 1 | |a Sivendran, Shanthi |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jinbo |e verfasserin |4 aut | |
| 700 | 1 | |a Volpp, Kevin G |e verfasserin |4 aut | |
| 700 | 1 | |a Bekelman, Justin E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ open |d 2012 |g 13(2023), 3 vom: 24. März, Seite e069468 |w (DE-627)NLM215724372 |x 2044-6055 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:3 |g day:24 |g month:03 |g pages:e069468 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjopen-2022-069468 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 3 |b 24 |c 03 |h e069468 | ||